Floatz logo

(+)-VINCRISTINE

Advanced Pancreatic Neuroendocrine Tumor

M.D. Anderson Cancer CenterSmall moleculePhase 2/3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced Pancreatic Neuroendocrine Tumor cohort.

Asset / SponsorPhaseRating
Octreotide Pamoate
National Cancer Institute (NCI)
Phase 2BB

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →